Chemistry:Alpiropride
From HandWiki
Alpiropride (INN; brand name Revistel, Rivistel, or Rivestel) is a dopamine D2 receptor antagonist of the benzamide group related to sulpiride.[1][2][3][4][5] It is described as an antihypertensive agent and has been marketed for use as an antimigraine medication in Portugal.[1][4][2] The drug was first described by 1980[1] and was introduced for medical use by 1989.[4] It remained marketed in Portugal as late as 2000.[2]
References
- ↑ 1.0 1.1 1.2 The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. 2014. p. 33. ISBN 978-1-4757-2085-3. https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA33. Retrieved 24 October 2024.
- ↑ 2.0 2.1 2.2 Schweizerischer Apotheker-Verein (2000). Index Nominum 2000: International Drug Directory. Medpharm Scientific Publishers. p. 31. ISBN 978-3-88763-075-1. https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA31. Retrieved 24 October 2024.
- ↑ Drugs: Synonyms and Properties. Routledge Revivals. Taylor & Francis. 2018. p. 358. ISBN 978-1-351-78990-5. https://books.google.com/books?id=dloPEAAAQBAJ&pg=PA358. Retrieved 24 October 2024.
- ↑ 4.0 4.1 4.2 "Chapter 31. To Market, To Market -1988". Annual Reports in Medicinal Chemistry. 24. Elsevier. 1989. pp. 295–315. doi:10.1016/s0065-7743(08)60553-9. ISBN 978-0-12-040524-4.
- ↑ "Molecular modeling and structural analysis of benzamide derivatives with and without extrapyramidal syndrome side effects.". Current Medicinal Chemistry. 4. Bentham Science Publishers. August 1997. pp. 271-278 (275). https://books.google.com/books?id=wufUIdeynGsC&pg=PA275. Retrieved 24 October 2024.
 |  |
